|
|
Industry
Update: Revisions to the Medical Devices Directive
Helen Colquhoun, MD
CEO Pleiad Devices
Purchase
recording US$199
|
 |
Register
for this Audio Conference
Due
to the widely held view that certain aspects needed to be clarified,
the EU Medical Devices Directive (MDD) is being revised. A number
of proposed revisions have been under consideration for over a
year now. Among the likely changes, there will be an increased
demand for clinical data and post-market surveillance. In this
audio conference, Dr. Helen Colquhoun will provide an update on
the review progress, and describe the revisions, giving detail
on those of greatest importance to device companies.
This
audio conference will cover:
- The current
status of implementation of revisions to the Medical Devices
Directive
- Details
of the more important revisions, particularly those pertaining
to clinical data and post-market surveillance
- The implications
these revisions will have for medical device manufacturers,
whether based in the USA or EU
About
the speaker:
Helen
Colquhoun holds degrees in Genetics and Medicine from the University
of Edinburgh and spent several years practising clinical medicine
before entering the life science industry in 1988. Initially working
in the UK in the pharmaceutical industry, Helen set up as an independent
consultant in 1995. Since that time she has spent increasingly
more time working with medical device and drug delivery companies
in the USA and EU. In 2000 she co-founded the Pleiad group of
companies and is currently CEO of Pleiad Devices, a clinical research
organization based in the USA and Europe that specializes in clinical
research and regulatory support for medical device companies.
Helen runs Pleiad's North American operation and is based in Cambridge,
Massachusetts.
Who should
attend?
- Regulatory
Associates/Managers
- Clinical
Research Associates/Managers
- Product
Development Managers
- Marketing
Executives
- Senior/Operational
Management Team Members
This
audio conference is classified as General Interest.
Registration
Options
|